how renal dysfunction relates to hemodynamics and mortality in pulmonary arterial hypertension (pah) remains unclear.
肾功能不全与血液动力学和肺动脉高压病死率相关性目前并不清楚。
aim: to explore the effect of exogenous carbon monoxide (co) on the hypoxic pulmonary arterial hypertension in the rat.
目的:探讨外源性低浓度一氧化碳(co)在低氧性肺动脉高压中的作用。
therefore, the present authors conclude that fenfluramine exposure characterises a potent trigger for pulmonary arterial hypertension without influencing its clinical course.
因此,芬氟拉明的服用仅是肺动脉高压潜在的触发因素,不会影响临床进程。
background— congenital heart disease can be complicated by pulmonary arterial hypertension (pah), the reversibility of which is often difficult to predict.
背景-——先心病由于肺动脉高压而变得更加复杂,肺动脉高压的可逆性常难以预测。
objective to investigate the prevalence, clinical features and prognosis of pulmonary arterial hypertension (pah) in maintenance hemodialysis (mhd) patients for early diagnosis and treatment.
目的探讨慢性肾衰竭血液透析(hd)患者并发肺动脉高压(pah)的发生率和临床特点,以便早期诊断pah并进行干预。
objective to study the effect of san'aoxiongting mixture(saxtm) on experimental hypoxemia pulmonary arterial hypertension and investigate its mechanism.
目的研究中药复方制剂三拗芎葶合剂对实验性低氧性肺动脉高压功能形态学的影响,并初步探讨其作用机制。
childhood pulmonary arterial hypertension is certainly a real disease, and according to doctors the drug seems to be both effective and well-tolerated by patients.
儿童肺动脉高血压当然是一种确实存在的疾病,而且据医生们描述,该药似乎有效,同时患者可承受药物的作用。
objective cardiopulmonary exercise test is used for early detection of exercise induced hypoxia and exercise induced pulmonary arterial hypertension of chronic obstructive pulmonary disease (copd).
目的应用运动心肺负荷试验早期检出慢性阻塞性肺疾病(copd)运动性低氧血癥及运动性肺动脉高压。
pulmonary arterial hypertension (pah) can complicate several types of congenital heart disease, and its reversibility is often difficult to predict.
很多类型的先天性心脏病由于发生肺动脉高压而变得更加复杂,并且肺高压的可逆性常难以预测。
objective to investigate the effect of carbon monoxide (co) inhalation on acute hypoxic pulmonary arterial hypertension and acute hypoxic lung injury.
目的研究吸入一氧化碳(co)对急性缺氧性肺动脉高压及缺氧性肺损伤的影响。
prostanoids, endothelin-receptor antagonists, and phosphodiesterase inhibitors are 3 types of the newest, most potent drugs for the treatment of pulmonary arterial hypertension nowadays.
前列环素类似物、内皮素受体拮抗药和磷酸二酯酶抑制药是目前肺动脉高压治疗的最新、最有效的3类药物。